{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:22:17Z","timestamp":1765959737522},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1745-6215-15-147","type":"journal-article","created":{"date-parts":[[2014,4,27]],"date-time":"2014-04-27T01:07:07Z","timestamp":1398560827000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Nicholas J A","family":"Webb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Frew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A","family":"Brettell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V","family":"Milford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Bockenhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moin A","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Christian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela S","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ania","family":"Koziell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivram","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney D","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"McKeever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie J","family":"Ives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,27]]},"reference":[{"key":"2049_CR1","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s004670100021","volume":"15","author":"PA McKinney","year":"2001","unstructured":"McKinney PA, Feltblower RG, Brocklebank JT, Fitzpatrick MM: Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 2001, 15: 1040-1044.","journal-title":"Pediatr Nephrol"},{"key":"2049_CR2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(85)91387-X","volume":"1","author":"RS Trompeter","year":"1985","unstructured":"Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS: Long-term outcome for children with minimal change nephrotic syndrome. Lancet. 1985, 1: 368-370.","journal-title":"Lancet"},{"issue":"5","key":"2049_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00467-009-1417-1","volume":"25","author":"M Shenoy","year":"2010","unstructured":"Shenoy M, Plant ND, Lewis MA, Bradbury MG, Lennon R, Webb NJ: Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome. Pediatr Nephrol. 2010, 25 (5): 899-903. 10.1007\/s00467-009-1417-1.","journal-title":"Pediatr Nephrol"},{"key":"2049_CR4","first-page":"239","volume":"95","author":"International Study of Kidney Disease in Children","year":"1982","unstructured":"International Study of Kidney Disease in Children: Nephrotic syndrome in children: a randomised controlled trial comparing two prednisone regimens in steroid-responsive patients who relapse early. J Pediatr. 1982, 95: 239-243.","journal-title":"J Pediatr"},{"key":"2049_CR5","volume-title":"Evidence-based Nephrology","author":"NJA Webb","year":"2008","unstructured":"Webb NJA: Epidemiology and general management of childhood idiopathic nephrotic syndrome. Evidence-based Nephrology. Edited by: Molony D, Craig J. 2008, Oxford, UK: Wiley-Blackwell"},{"issue":"12","key":"2049_CR6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00467-003-1295-x","volume":"18","author":"AS Hall","year":"2003","unstructured":"Hall AS, Thorley G, Houtman PN: The effects of corticosteroids on behaviour in children with nephrotic syndrome. Pediatr Nephrol. 2003, 18 (12): 1220-1223. 10.1007\/s00467-003-1295-x.","journal-title":"Pediatr Nephrol"},{"key":"2049_CR7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0022-3476(86)80876-9","volume":"108","author":"N MacDonald","year":"1986","unstructured":"MacDonald N, Wolfish N, McLaine P, Phipps P, Rossier E: Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Paediatr. 1986, 108: 378-382. 10.1016\/S0022-3476(86)80876-9.","journal-title":"J Paediatr"},{"key":"2049_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000045684","volume":"85","author":"TK Mattoo","year":"2000","unstructured":"Mattoo TK, Mahmoud MA: Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome. Nephron. 2000, 85: 343-345. 10.1159\/000045684.","journal-title":"Nephron"},{"key":"2049_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/adc.2007.116079","volume":"93","author":"AS Abeyagunawardena","year":"2008","unstructured":"Abeyagunawardena AS, Trompeter RS: Increasing the dose of prednisolone during viral infection reduced the risk of relapse in nephrotic syndrome: a randomised controlled trial. Arch Dis Child. 2008, 93: 226-228. 10.1136\/adc.2007.116079.","journal-title":"Arch Dis Child"},{"key":"2049_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2215\/CJN.01850310","volume":"6","author":"A Gulati","year":"2011","unstructured":"Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A: Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomised controlled trial. Clin J Am Soc Nephrol. 2011, 6: 63-69. 10.2215\/CJN.01850310.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2049_CR11","volume-title":"Sample Size Tables for Clinical Studies","author":"D Machin","year":"2009","unstructured":"Machin D, Campbell MJ, Tan SB, Tan SH: Sample Size Tables for Clinical Studies. 2009, Chichester: Wiley-Blackwell, 3","edition":"3"},{"key":"2049_CR12","doi-asserted-by":"publisher","first-page":"C332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D: CONSORT Group: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010, 340: C332-10.1136\/bmj.c332.","journal-title":"BMJ"},{"key":"2049_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f6tzsche PC, Krle\u017ea-Jeri\u0107 K, Hr\u00f3bjartsson A, Mann H, Dickersin K, Berlin JA, Dor\u00e9 CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D: SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013, 158: 200-207. 10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med"},{"key":"2049_CR14","unstructured":"PREDNOS 2. [\n                    http:\/\/www.birmingham.ac.uk\/prednos2\n                    \n                  ]"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:27:37Z","timestamp":1548214057000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-15-147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,27]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2049"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-15-147","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,27]]},"assertion":[{"value":"9 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"147"}}